Chemical Industry News, Data & Insights

Boehringer Ingelheim

About Boehringer Ingelheim

Boehringer Ingelheim is a research-driven, privately held pharmaceutical company headquartered in Ingelheim am Rhein, Germany. Founded in 1885, the group develops and markets prescription medicines for human health and a broad range of products for animal health. Its R&D spans therapeutic areas such as cardiovascular-metabolic diseases, respiratory disorders, oncology, immunology, and central nervous system conditions, alongside vaccines and parasiticides in animal health. The company operates a global network of research, development, and manufacturing sites across Europe, the Americas, and Asia.

For the chemical and life-sciences value chain, Boehringer Ingelheim is active in the development and manufacture of small-molecule active pharmaceutical ingredients and finished dosage forms, as well as biopharmaceuticals produced via cell culture and fermentation. Capabilities include chemical process development, scale-up, sterile manufacturing, and quality-controlled vaccine formulation and filling. The company emphasizes high regulatory standards, supply reliability, and ongoing investment in modern production technologies and sustainability across its operations.

Get insights on Boehringer Ingelheim
with chemXplore Analytics